Metabolic Soft Spot and Pharmacokinetics: Functionalization of C-3 Position of an Eph-Ephrin Antagonist Featuring a Bile Acid Core as an Effective Strategy to Obtain Oral Bioavailability in Mice
UniPR129, an L-β-homotryptophan conjugate of the secondary bile acid lithocholic acid (LCA), acts as an effective protein-protein interaction (PPI) inhibitor of the Eph-ephrin system but suffers from a poor oral bioavailability in mice. To improve UniPR129 bioavailability, a metabolic soft spot, i.e...
Saved in:
Main Authors: | Francesca Ferlenghi (Author), Carmine Giorgio (Author), Matteo Incerti (Author), Lorenzo Guidetti (Author), Paola Chiodelli (Author), Marco Rusnati (Author), Massimiliano Tognolini (Author), Federica Vacondio (Author), Marco Mor (Author), Alessio Lodola (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protein-Protein Interaction Inhibitors Targeting the Eph-Ephrin System with a Focus on Amino Acid Conjugates of Bile Acids
by: Lorenzo Guidetti, et al.
Published: (2022) -
A Pharmacological Investigation of Eph-Ephrin Antagonism in Prostate Cancer: UniPR1331 Efficacy Evidence
by: Claudio Festuccia, et al.
Published: (2023) -
Evaluation of the Anti-Tumor Activity of Small Molecules Targeting Eph/Ephrins in APC <sup>min</sup>/J Mice
by: Miriam Corrado, et al.
Published: (2020) -
Targeting the Eph/Ephrin System as Anti-Inflammatory Strategy in IBD
by: Andrea Grandi, et al.
Published: (2019) -
UniPR1331: Small Eph/Ephrin Antagonist Beneficial in Intestinal Inflammation by Interfering with Type-B Signaling
by: Carmine Giorgio, et al.
Published: (2021)